JAK/HDAC-IN-1

Modify Date: 2025-09-11 12:50:01

JAK/HDAC-IN-1 Structure
JAK/HDAC-IN-1 structure
Common Name JAK/HDAC-IN-1
CAS Number 2284621-75-4 Molecular Weight 450.32
Density N/A Boiling Point N/A
Molecular Formula C19H21Cl2N7O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of JAK/HDAC-IN-1


JAK/HDAC-IN-1 is a potent JAK2/HDAC dual inhibitor, exhibits antiproliferative and proapoptotic activities in several hematological cell lines. JAK/HDAC-IN-1 shows IC50s of 4 and 2 nM for JAK2 and HDAC, respectively[1].

 Names

Name JAK/HDAC-IN-1

 JAK/HDAC-IN-1 Biological Activity

Description JAK/HDAC-IN-1 is a potent JAK2/HDAC dual inhibitor, exhibits antiproliferative and proapoptotic activities in several hematological cell lines. JAK/HDAC-IN-1 shows IC50s of 4 and 2 nM for JAK2 and HDAC, respectively[1].
Related Catalog
Target

JAK2:4 nM (IC50)

JAK1:4.8 nM (IC50)

JAK3:7.4 nM (IC50)

Tyk2:49 nM (IC50)

HDAC:2 nM (IC50)

HDAC2:14 nM (IC50)

HDAC6:120 nM (IC50)

HDAC8:2470 nM (IC50)

In Vitro JAK/HDAC-IN-1 (Compound 8m) exhibits IC50s of 4.8, 7.4 and 49 nM for JAK1, JAK3 and TYK2, and 14, 120, 2470 nM for HDAC2, HDAC6 and HDAC8, respectively[1].
References

[1]. Liang X, et al. Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies. J Med Chem. 2019 Apr 25;62(8):3898-3923.

 Chemical & Physical Properties

Molecular Formula C19H21Cl2N7O2
Molecular Weight 450.32
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.